AAAAAA

   
Results: 1-25 |
Results: 25
Platelets and phospholipids in tissue factor-initiated thrombin generation
Authors: Butenas, S Branda, RF van't Veer, C Cawthern, KM Mann, KG
Citation: S. Butenas et al., Platelets and phospholipids in tissue factor-initiated thrombin generation, THROMB HAEM, 86(2), 2001, pp. 660-667
Homocysteine inhibits inactivation of Factor Va by activated protein C
Authors: Undas, A Williams, EB Butenas, S Orfeo, T Mann, KG
Citation: A. Undas et al., Homocysteine inhibits inactivation of Factor Va by activated protein C, J BIOL CHEM, 276(6), 2001, pp. 4389-4397
The role of the membrane in the inactivation of factor Va by plasmin - Amino acid region 307-348 of factor V plays a critical role in factor Va cofactor function
Authors: Kalafatis, M Mann, KG
Citation: M. Kalafatis et Kg. Mann, The role of the membrane in the inactivation of factor Va by plasmin - Amino acid region 307-348 of factor V plays a critical role in factor Va cofactor function, J BIOL CHEM, 276(21), 2001, pp. 18614-18623
PIA2 polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury
Authors: Undas, A Brummel, K Musial, J Mann, KG Szczeklik, A
Citation: A. Undas et al., PIA2 polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury, CIRCULATION, 104(22), 2001, pp. 2666-2672
Oral anticoagulation thresholds
Authors: Brummel, KE Paradis, SG Branda, RF Mann, KG
Citation: Ke. Brummel et al., Oral anticoagulation thresholds, CIRCULATION, 104(19), 2001, pp. 2311-2317
Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation
Authors: Undas, A Brummel, KE Musial, J Mann, KG Szczeklik, A
Citation: A. Undas et al., Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation, CIRCULATION, 103(18), 2001, pp. 2248-2253
Blood coagulation at the site of microvascular injury: effects of low-doseaspirin
Authors: Undas, A Brummel, K Musial, J Mann, KG Szczeklik, A
Citation: A. Undas et al., Blood coagulation at the site of microvascular injury: effects of low-doseaspirin, BLOOD, 98(8), 2001, pp. 2423-2431
Antiplatelet agents in tissue factor-induced blood coagulation
Authors: Butenas, S Cawthern, KM van't Veer, C DiLorenzo, ME Lock, JB Mann, KG
Citation: S. Butenas et al., Antiplatelet agents in tissue factor-induced blood coagulation, BLOOD, 97(8), 2001, pp. 2314-2322
Models of blood coagulation
Authors: Butenas, S van't Veer, C Cawthern, K Brummel, KE Mann, KG
Citation: S. Butenas et al., Models of blood coagulation, BL COAG FIB, 11, 2000, pp. S9-S13
Issues with the assay of factor VIII activity in plasma and factor VIII concentrates
Authors: Lundblad, RL Kingdon, HS Mann, KG White, GC
Citation: Rl. Lundblad et al., Issues with the assay of factor VIII activity in plasma and factor VIII concentrates, THROMB HAEM, 84(6), 2000, pp. 942-948
How much factor v is enough?
Authors: Mann, KG
Citation: Kg. Mann, How much factor v is enough?, THROMB HAEM, 83(1), 2000, pp. 3-4
Bone marrow accessory cells regulate human bone precursor cell development
Authors: Eipers, PG Kale, S Taichman, RS Pipia, GG Swords, NA Mann, KG Long, MW
Citation: Pg. Eipers et al., Bone marrow accessory cells regulate human bone precursor cell development, EXP HEMATOL, 28(7), 2000, pp. 815-825
The regulation of the factor VII-dependent coagulation pathway: Rationale for the effectiveness of recombinant factor VIIa in refractory bleeding disorders
Authors: van't Veer, C Mann, KG
Citation: C. Van'T Veer et Kg. Mann, The regulation of the factor VII-dependent coagulation pathway: Rationale for the effectiveness of recombinant factor VIIa in refractory bleeding disorders, SEM THROMB, 26(4), 2000, pp. 367-372
Novel, bedside, tissue factor-dependent clotting assay permits improved assessment of combination antithrombotic and antiplatelet therapy
Authors: Holmes, MB Schneider, DJ Hayes, MG Sobel, BE Mann, KG
Citation: Mb. Holmes et al., Novel, bedside, tissue factor-dependent clotting assay permits improved assessment of combination antithrombotic and antiplatelet therapy, CIRCULATION, 102(17), 2000, pp. 2051-2057
Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa
Authors: van't Veer, C Golden, NJ Mann, KG
Citation: C. Van'T Veer et al., Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa, BLOOD, 95(4), 2000, pp. 1330-1335
Self-association of human protein S
Authors: Pauls, JED Hockin, MF Long, GL Mann, KG
Citation: Jed. Pauls et al., Self-association of human protein S, BIOCHEM, 39(18), 2000, pp. 5468-5473
Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis
Authors: Bini, A Mann, KG Kudryk, BJ Schoen, FJ
Citation: A. Bini et al., Noncollagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis, ART THROM V, 19(8), 1999, pp. 1852-1861
Phenotype and genotype expression in pseudohomozygous factor V-LEIDEN - The need for phenotype analysis
Authors: Kalafatis, M Bernardi, F Simioni, P Lunghi, B Girolami, A Mann, KG
Citation: M. Kalafatis et al., Phenotype and genotype expression in pseudohomozygous factor V-LEIDEN - The need for phenotype analysis, ART THROM V, 19(2), 1999, pp. 336-342
Age-related phenotypic alterations in populations of purified human bone precursor cells
Authors: Long, MW Ashcraft, EK Normalle, D Mann, KG
Citation: Mw. Long et al., Age-related phenotypic alterations in populations of purified human bone precursor cells, J GERONT A, 54(2), 1999, pp. B54-B62
Biochemistry and physiology of blood coagulation
Authors: Mann, KG
Citation: Kg. Mann, Biochemistry and physiology of blood coagulation, THROMB HAEM, 82(2), 1999, pp. 165-174
Regulation of prothrombinase activity by protein S
Authors: van't Veer, C Butenas, S Golden, NJ Mann, KG
Citation: C. Van'T Veer et al., Regulation of prothrombinase activity by protein S, THROMB HAEM, 82(1), 1999, pp. 80-87
Blood coagulation
Authors: Mann, KG
Citation: Kg. Mann, Blood coagulation, ALC CLIN EX, 23(6), 1999, pp. 1111-1113
An integrated study of fibrinogen during blood coagulation
Authors: Brummel, KE Butenas, S Mann, KG
Citation: Ke. Brummel et al., An integrated study of fibrinogen during blood coagulation, J BIOL CHEM, 274(32), 1999, pp. 22862-22870
"Normal" thrombin generation
Authors: Butenas, S van't Veer, C Mann, KG
Citation: S. Butenas et al., "Normal" thrombin generation, BLOOD, 94(7), 1999, pp. 2169-2178
A model describing the inactivation of factor Va by APC: Bond cleavage, fragment dissociation, and product inhibition
Authors: Hockin, MF Cawthern, KM Kalafatis, M Mann, KG
Citation: Mf. Hockin et al., A model describing the inactivation of factor Va by APC: Bond cleavage, fragment dissociation, and product inhibition, BIOCHEM, 38(21), 1999, pp. 6918-6934
Risultati: 1-25 |